141 related articles for article (PubMed ID: 16730667)
1. Novel amidine analogue of melphalan as a specific multifunctional inhibitor of growth and metabolism of human breast cancer cells.
Bielawski K; Bielawska A; Sosnowska K; Miltyk W; Winnicka K; Pałka J
Biochem Pharmacol; 2006 Jul; 72(3):320-31. PubMed ID: 16730667
[TBL] [Abstract][Full Text] [Related]
2. Amidine analogues of melphalan: synthesis, cytotoxic activity, and DNA binding properties.
Bielawska A; Bielawski K; Anchim T
Arch Pharm (Weinheim); 2007 May; 340(5):251-7. PubMed ID: 17458920
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic efficacy of a novel dinuclear platinum(II) complex in human breast cancer cells.
Bielawska A; Popławska B; Surazyński A; Czarnomysy R; Bielawski K
Eur J Pharmacol; 2010 Sep; 643(1):34-41. PubMed ID: 20598681
[TBL] [Abstract][Full Text] [Related]
4. Amidine analogue of chlorambucil is a stronger inhibitor of protein and DNA synthesis in breast cancer MCF-7 cells than is the parent drug.
Sienkiewicz P; Bielawski K; Bielawska A; Pałka J
Eur J Pharmacol; 2004 May; 492(2-3):95-101. PubMed ID: 15178351
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of collagen and DNA biosynthesis by a novel amidine analogue of chlorambucil is accompanied by deregulation of β(1)-integrin and IGF-I receptor signaling in MDA-MB 231 cells.
Sienkiewicz P; Bielawski K; Bielawska A; Pałka J
Environ Toxicol Pharmacol; 2005 Jul; 20(1):118-24. PubMed ID: 21783578
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule based delivery systems for alkylating antineoplastic compounds.
Bielawski K; Bielawska A
ChemMedChem; 2008 Apr; 3(4):536-42. PubMed ID: 18157855
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxic activity of novel amidine analogues of bis(2-chloroethyl)amine.
Bielawski K; Bielawska A; Poplawska B
Arch Pharm (Weinheim); 2009 Aug; 342(8):484-90. PubMed ID: 19565602
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
9. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.
Pu QQ; Bezwoda WR
Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328
[TBL] [Abstract][Full Text] [Related]
10. Proline-linked nitrosoureas as prolidase-convertible prodrugs in human breast cancer cells.
Bielawski K; Bielawska A; Słodownik T; Bołkun-Skórnicka U; Muszyńska A
Pharmacol Rep; 2008; 60(2):171-82. PubMed ID: 18443378
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity studies of novel amidine analogues of chlorambucil: correlation of cytotoxic activity with DNA-binding affinity and topoisomerase II inhibition.
Bielawska A; Bielawski K; Wołczyński S; Anchim T
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):293-9. PubMed ID: 12953217
[TBL] [Abstract][Full Text] [Related]
12. Nutritional concentration of genistein protects human dermal fibroblasts from oxidative stress-induced collagen biosynthesis inhibition through IGF-I receptor-mediated signaling.
Sienkiewicz P; Surazyński A; Pałka J; Miltyk W
Acta Pol Pharm; 2008; 65(2):203-11. PubMed ID: 18666426
[TBL] [Abstract][Full Text] [Related]
13. Acetylsalicylic acid-dependent inhibition of collagen biosynthesis and beta1-integrin signaling in cultured fibroblasts.
Surazyński A; Pałka J; Wołczyński S
Med Sci Monit; 2004 Jun; 10(6):BR175-9. PubMed ID: 15173663
[TBL] [Abstract][Full Text] [Related]
14. The effect of a novel dinuclear platinum complex with berenil and 2-picoline ligands on growth of human breast cancer cells.
Bielawski K; Bielawska A; Popławska B; Surazyński A; Czarnomysy R
Acta Pol Pharm; 2010; 67(6):609-14. PubMed ID: 21229875
[TBL] [Abstract][Full Text] [Related]
15. Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
Chrzanowski K; Pałka J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():209-11. PubMed ID: 11820612
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
17. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
18. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
Chrzanowski K; Bielawska A; Pałka J
Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
[TBL] [Abstract][Full Text] [Related]
19. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
20. Aromatic analogues of DNA minor groove binders--synthesis and biological evaluation.
Pućkowska A; Bielawski K; Bielawska A; Midura-Nowaczek K
Eur J Med Chem; 2004 Jan; 39(1):99-105. PubMed ID: 14987838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
